We have shown that NOX4 is an important regulator of TGF-β1 mediated myCAF activation [13] and that NOX4 inhibition can reduce ECM deposition and CAF-mediated tumour cell invasion and migration [1, 13, 51]. Here, NOX4 is linked to neoplasm.